mobile navigation
TIRN logo
mobile navigation

Transplantation and Immunology Research Network

american society of transplantation

Conflict of Interest Disclosure

Members of the American Society of Transplantation (AST) Transplantation and Immunology Research Network (TIRN)℠ Committee are asked to disclose any financial relationships of any amount occurring within the past 12 months and during their committee term that they or their spouse/partner have with any commercial interest. A commercial interest is defined as an entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

The AST Conflict of Interest (COI) Committee is responsible for reviewing all disclosures of potential conflicts of interest, and must determine for each reported relationship whether or not that relationship represents an actual conflict of interest relevant to the duties of the committee, or represents no conflict of interest. If a relationship is found to represent an actual conflict of interest, steps are taken to resolve/remove the potential conflict of interest. Resolutions include individuals recusing themselves from certain projects or discussions where the conflict may exist, or altering the relationship to remove the potential conflict. Removal from the committee is also a possible resolution, when no other resolution is sufficient.

The following committee members reported a potential conflict of interest. The COI committee found no that no actual conflict exists related to the duties of the committee. Reported relationships are re-examined before the start of each project to ensure there are no project-specific conflicts.

Name

Relationship and Entity

Anil Chandraker Grant Support relationship with NIH Grant
Consultant relationship with Astellas
Consultant relationship with Novartis
Consultant relationship with UpToDate
Consultant relationship with RAPharma
Consultant relationship with Dompe
Consultant relationship with NPA
Consultant relationship with Shire Pharmaceuticals
Consultant relationship with Alexion
Mandy Ford Consultant relationship with Bristol Myers Squibb
Robert Gaston Advisory Board relationship with Immucor
Associate Editor relationship with American Society of Nephrology
Ronald Gill Consultant relationship with PureTech
Michael Ison Grant Support relationship with Gilead
Grant Support relationship with Alios/Jensen
Grant Support relationship with Beckman Coulter
Grant Support relationship with Chimerix
Consultant relationship with Seqirus
Consultant relationship with Shionogi
Other relationship with Genentech/Roche
Other relationship with International Society of Influenza and Other
Respiratory Viruses
Planning Committee relationship with ICAAC
Jonathan Maltzman Employment relationship with Gilead
Committee relationship with Global Virtual Laboratory
Steering Committee Member relationship with Federation of Clinical
Immunology Societies
Kenneth Newell Consultant relationship with Novartis
Consultant relationship with Immucor
Consultant relationship with Merck
Consultant relationship with Medeor
Speaker relationship with Novartis
Advisory Board relationship with Novartis
Board of Directors relationship with Donate Life America

The following committee members reported that they had no relevant financial relationships to disclose:
Robert Fairchild
Sheri Krams
Dianne McKay

Disclaimer

The content, information, opinions, and viewpoints contained on this website and in any downloadable materials are those of the authors or contributors of such materials. While the AST and the TIRN committee take great care to screen the credentials of the contributors and review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content herein. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this website is strictly at your own risk.

The information and material contained herein is meant to promote the general understanding and dialog of transplantation topics by healthcare professionals and related parties in the transplantation field. Such information is not meant or intended to serve as a substitute for a healthcare professional's clinical training, experience, or judgment. For patients and individuals, such information is not to be a substitute for professional medical, therapeutic, or healthcare advice or counseling. For medical issues or concerns, including decisions about medications and other treatments, readers should always consult their physician or, in serious cases, seek immediate assistance from emergency personnel. Prescription information, procedures, and use of medical devices information should be undertaken only by properly trained and certified medical personnel after confirmation of information from third party sources, including by consulting the FDA-approved uses and information.

AST specifically disclaims any warranties, express or implied, including implied warranties of merchantability or fitness for a particular purpose. Such information is provided "AS IS" and is believed to be accurate at the time of its publishing, but it is the reader's job to evaluate the accuracy of any information found on the site. If you are a healthcare professional, you should rely on your professional judgment in evaluating any and all information, and confirm the information contained on the AST website with other sources and reliable third parties before undertaking any treatment based on it. If you are a consumer or patient, you should evaluate the information together with your physician or another qualified healthcare professional. AST makes no warranty that the information contained herein will be error free, and the readers of such information use such at their OWN RISK.

Privacy Policy and Terms of Use

You may also be interested in reviewing the AST TIRN website privacy policy and the website terms of use.